| Product Code: ETC6143528 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Oncology NGS Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Oncology NGS Market - Industry Life Cycle |
3.4 Argentina Oncology NGS Market - Porter's Five Forces |
3.5 Argentina Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Argentina Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Argentina Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Argentina Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Argentina Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Argentina Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in Argentina |
4.2.2 Growing adoption of precision medicine in oncology |
4.2.3 Technological advancements in next-generation sequencing (NGS) for oncology research |
4.3 Market Restraints |
4.3.1 High cost associated with NGS technology and testing |
4.3.2 Limited access to advanced oncology care in certain regions of Argentina |
5 Argentina Oncology NGS Market Trends |
6 Argentina Oncology NGS Market, By Types |
6.1 Argentina Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Argentina Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Argentina Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Argentina Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Argentina Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Argentina Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Argentina Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Argentina Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Argentina Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Argentina Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Argentina Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Argentina Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Argentina Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Argentina Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Argentina Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Argentina Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Argentina Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Argentina Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Argentina Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Argentina Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Argentina Oncology NGS Market Import-Export Trade Statistics |
7.1 Argentina Oncology NGS Market Export to Major Countries |
7.2 Argentina Oncology NGS Market Imports from Major Countries |
8 Argentina Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing in oncology |
8.2 Number of clinical trials utilizing NGS technology in oncology research |
8.3 Percentage of oncologists using NGS for treatment decision-making |
9 Argentina Oncology NGS Market - Opportunity Assessment |
9.1 Argentina Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Argentina Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Argentina Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Argentina Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Argentina Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Argentina Oncology NGS Market - Competitive Landscape |
10.1 Argentina Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Argentina Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here